Midtrimester cervical ripening and labor induction

Clinical Obstetrics and Gynecology

Volumn 43, Issue 3, 2000, Pages 495-512

  Ramsey, Patrick S ^a   Owen, John ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXYTOCIC AGENT;

FEMALE; HUMAN; LABOR COMPLICATION; LABOR INDUCTION; PREGNANCY; REVIEW; UTERINE CERVIX RIPENING;

CERVICAL RIPENING; FEMALE; HUMANS; LABOR, INDUCED; OBSTETRIC LABOR COMPLICATIONS; OXYTOCICS; PREGNANCY; PREGNANCY TRIMESTERS;

EID: 0034266597     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200009000-00010     Document Type: Article

References (87)

1. Koonin LM, Strauss LT, Chrisman CE, Montalbano MA, Bartlett LA, Smith JC. Abortion Surveillance - United States, 1996. MMWR Morb Mortal Wkly Rep 1999;48:1-42.
2. Lawson HW, Frye A, Atrash HK, Smith JC, Shulman HB, Ramick M. Abortion mortality, United States, 1972 through 1987. Am J Obstet Gynecol. 1994;171:1365-1372.
3. Blumenthal PD, Castleman LD, Jain JK. Abortion by labor induction. In: Paul M, Lichtenberg ES, Borgatta L, Grimes DA, Stubblefield PG, eds. A Clinician's Guide to Medical and Surgical Abortion. New York, NY: Churchill Livingstone, 1999:139-154.
4. Grimes DA, Schulz KF. Morbidity and mortality from second-trimester abortions. J Reprod Med. 1985;30:505-514.
5. 2α versus dilatation and evacuation. JAMA. 1984;251:916-919.
6. Grimes DA, Schulz KF, Cates W Jr, Tyler CW Jr. Midtrimester abortion by dilatation and evacuation. N Engl J Med. 1977;296: 1141-1145.
7. 2. J Reprod Med. 1982;27: 415-419.
8. Grimes DA, Schulz KF, Cates W Jr. Prevention of uterine perforation during curettage abortion. JAMA. 1984;251:2108-2111.
9. Grimes DA. Clinicians who provide abortion: The thinning ranks. Obstet Gynecol. 1992;80:719-723.
10. Westhoff C, Marks F, Rosenfield A. Residency training in contraception, sterilization and abortion. Obstet Gynecol. 1993; 81:311-314.
11. Ye BL, Yamamoto K, Tyson JE. Functional and biochemical aspects of laminaria use in first-trimester pregnancy termination. Am J Obstet Gynecol. 1982;142:36-39.
12. Wheeler RG, Schneider K. Properties and safety of cervical dilators. Am J Obstet Gynecol. 1983;146:597-601.
13. 2α with urea and intravenous oxytocin. Am J Obstet Gynecol. 1979;134:260-264.
14. 2α for midtrimester pregnancy termination. Prostaglandins. 1975;10:413-422.
15. Stubblefield PG, Altman AM, Goldstein SP. Randomized trial of one versus two days of laminaria treatment prior to late midtrimester abortion by uterine evacuation: A pilot study. Am J Obstet Gynecol. 1982;143:481-482.
16. Tan SL, Cheng H, Ho KK, Mitra R, Hii J, Yeo KCY. Lamicel is more effective in preparing the cervix for midtrimester termination of pregnancy than laminaria japonicum. Aust NZ J Obstet Gynaecol. 1988;28: 49-52.
17. Grimes DA, Ray IG, Middleton CJ. Lamicel versus laminaria for cervical dilation before early second-trimester abortion: A randomized clinical trial. Obstet Gynecol. 1987;69:887-890.
18. Nicolaides KH, Welch CC, Koullapis EN, Filshie GM. Cervical dilatation by Lamicel: Studies on the mechanism of action. Br J Obstet Gynaecol. 1983;90:1060-1064.
19. Khanna NM, Sarin JPS, Nandi RC, et al. Isaptent: A new cervical dilator. Contraception. 1980;21:29-40.
20. Sema S, Hingorani V, Kumar S, Kinra G. Three methods for gradual cervical dilatation prior to vacuum aspiration in late first trimester pregnancy. Contraception. 1983; 28:223-231.
21. Blumenthal PD. Prospective comparison of Dilapan and laminaria for pretreatment of the cervix in second-trimester induction abortion. Obstet Gynecol. 1988;72:243-246.
22. Darney PD, Dorward K. Cervical dilation before first-trimester elective abortion: A controlled comparison of meteneprost, laminaria, and hypan. Obstet Gynecol. 1987;70:397-400.
23. Atad J, Bornstein J, Calderon I, Petrikovsky BM, Sorokin Y, Abramovici H. Nonpharmaceutical ripening of the unfavorable cervix and induction of labor by a novel double balloon device. Obstet Gynecol. 1991;77:146-152.
24. Manabe Y, Okazaki T, Takahashi A. Prostaglandins E and F in amniotic fluid during stretch-induced cervical softening and labor at term. Gynecol Obstet Invest 1983;15: 343-350.
25. Liu HS, Yu MH, Chang YK, Chu TY. Second and early third trimester pregnancy termination by extra-amniotic balloon and intracervical PGE2. Int J Gynecol Obstet. 1998;60:29-34.
26. Sherman D J, Frenkel E, Tovbin J, Arieli S, Caspi E, Bukovsky I. Ripening of the unfavorable cervix with extra-amniotic catheter balloon: Clinical experience and review. Obstet Gynecol Surv. 1996;51:621-627.
27. Gustavii B, Gothlin J. Radiographic study of extra-amniotically injected hypertonic saline in therapeutic abortion. Acta Obstet Gynecol Scand. 1971;50:315-320.
28. Keirse M J, Thiery M, Parewijck W, Mitchell MD. Chronic stimulation of uterine prostaglandin synthesis during cervical ripening before the onset of labor. Prostaglandins. 1983;25:671-682.
29. Blum M. Experience with the induction of second-trimester abortion by extra-amniotic physiological saline infusion. Report of 127 cases. Eur J Obstet Gynecol Reprod Biol. 1980;10:183-185.
30. Rofe A, Abramovici H, David A, Atad J, Lewin A. Extraovular instillations of normal saline for termination of midtrimester pregnancy. Int J Gynaecol Obstet. 1980;18: 351-353.
31. Hogg B, Owen J. Laminaria versus extra-amniotic saline infusion (EASI) for cervical ripening and midtrimester labor induction. Am J Obstet Gynecol 2000;182:8135.
32. 1 analog, for prelabor ripening of the unfavorable uterine cervix. Fetal Mat Med Rev. 1996:217-227.
33. Lauersen NH, Den T, Iliescu C, Wilson KH, Graves ZR. Cervical priming prior to dilatation and evacuation: A comparison of methods. Am J Obstet Gynecol. 1982;144: 890-894.
34. 2 pessaries and laminaria tents for ripening the cervix before termination of pregnancy. Br J Obstet Gynaecol. 1985;92:518-521.
35. Christensen NJ, Bygdeman M, Green K. Comparison of different prostaglandin analogues and laminaria for preoperative dilatation of the cervix in late first trimester abortion. Contraception. 1983;27:51-61.
36. 2 suppositories with or without intracervical Laminaria japonica: A randomized study. Obstet Gynecol. 1998;92:398-402.
37. Couzinet B, Le Strat N, Ulmann A, Baulieu EE, Schaison G. Termination of early pregnancy by the progesterone antagonist RU 486 (Mifepristone). N Engl J Med. 1986; 315:1565-1570.
38. Swahn ML, Bygdeman M. The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin. Br J Obstet Gynaecol. 1988;95:126-134.
39. Peyron R, Aubeny E, Targosz V, et al. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. N Engl J Med. 1993;328:1509-1513.
40. Grimes DA, Mishell DR, Shoupe D, Lacarra M. Early abortion with a single dose of the antiprogestin RU-486. Am J Obstet Gynecol. 1988;158:1307-1312.
41. Ho PC, Tsang SSK, Ma HK. Reducing the induction to abortion interval in termination of second trimester pregnancies: A comparison of mifepristone with laminaria tent. Br J Obstet Gynaecol. 1995;102:648-651.
42. Thong KJ, Baird DT. A study of gemeprost alone, Dilapan or mifepristone in combination with gemeprost for the termination of second trimester pregnancy. Contraception. 1992;46:11-17.
43. Rodger MW, Baird DT. Pretreatment with mifepristone (RU-486) reduces interval between prostaglandin administration and expulsion in the second trimester abortion. Br J Obstet Gynaecol. 1990;97:41-45.
44. Gottlieb C, Bygdeman M. The use of antiprogestin (RU 486) for termination of second trimester pregnancy. Acta Obstet Gynecol Scand. 1991;70:199-203.
45. Riddle JM, Estes JW, Russell JC. Ever since Eve. . . Birth control in the ancient world. Archaeology. 1993;47:29-35.
46. Ivanisevic M, Djelmis J. Amniotic fluid and maternal plasma prostaglandins in hypertonic saline induced abortion. Int J Gynaecol Obstet. 1990;31:355-359.
47. 2α and hypertonic saline for midtrimester abortion. Prostaglandins. 1976;12: 625-637.
48. Berger GS, Edelman DA, Kerenyi TD. Oxytocin administration, instillation-to-abortion time, and morbidity associated with saline instillation. Am J Obstet Gynecol. 1975;121:941-945.
49. Ghosh AK, Konar JR. The relative value of two concentrations of hypertonic saline for midtrimester abortion. Int J Gynaecol Obstet. 1980;17:368-371.
50. Burkman RT, Bell WR, Atienza MF, King TM. Coagulopathy with midtrimester induced abortion: Association with hyperosmolar urea administration. Am J Obstet Gynecol. 1977;127:533-536.
51. American College of Obstetricians and Gynecologist. Methods of midtrimester abortion. Technical Bulletin no. 109, October 1987.
52. Binkin NJ, Schulz KF, Grimes DA, Cates W Jr. Urea-prostaglandin versus hypertonic saline for instillation abortion. Am J Obstet Gynecol. 1983;146:947-952.
53. Bhathena RK, Sheriar NK, Walvekar VR, Guillebaud J. Second trimester pregnancy termination using extra-amniotic ethacridine lactate. Br J Obstet Gynaecol. 1990; 97:1026-1029.
54. Gardo S, Nagy M. Induction of second trimester abortion by intra-amniotic instillation of Rivanol (ethacridine) combined with oxytocin infusion. Arch Gynecol Obstet. 1990;247:39-41.
55. Yapar EG, Senoz S, Urkutur M, Batioglu S, Gokmen O. Second trimester pregnancy termination including fetal death: Comparison of five different methods. Eur J Obstet Gynecol Reprod Biol. 1996;69:97-102.
56. Olund A, Kindahl H, Oliw E, Lindgren JA, Larsson B. Prostaglandins and thromboxanes in amniotic fluid during rivanol-induced abortion and labour. Prostaglandins. 1980;19:791-803.
57. Fahmy K. Prophylaxis against prostaglandin-induced gastrointestinal side effects. Int J Gynaecol Obstet. 1981;19:487-489.
58. 2 suppositories as a second-trimester aborti-facient. J Reprod Med. 1988;33:817-820.
59. 2 suppositories. Am J Obstet Gynecol. 1975;122: 947-954.
60. 2α for pregnancy termination in the second and early third trimesters of pregnancy. J Reprod Med. 1997;42:235-238.
61. 2α: Safer than saline? Obstet Gynecol. 1977;49:612-616.
62. 2α in second trimester abortion: A pilot study. Obstet Gynecol. 1976;48:469-471.
63. Papageorgiou I, Minaretzis D, Tsionou C, Michalas S. Late midtrimester medical pregnancy terminations: Three different procedures with prostaglandin F2 alpha and laminaria tents. Prostaglandins. 1991;41:487-493.
64. Peat B. Second trimester abortion by extra-amniotic PGF2 alpha infusion: Experience of 178 cases. Aust NZ J Obstet Gynaecol. 1991;31:47-51.
65. 2 suppositories: A randomized trial. Obstet Gynecol. 1995;85:697-700.
66. 2 methylsulfonylamide. A randomized multicenter study. Int J Gynecol Obstet. 1988;26:129-135.
67. Scheepers HCJ, Van Erp EJM, Van de Bergh AS. Use of misoprostol in first and second trimester abortion: A review. Obstet Gynecol Surv. 1999;54:592-600.
68. Thong KJ, Baird DT. An open study comparing two regimens of gemeprost for the termination of pregnancy in the second trimester. Acta Obstet Gynecol Scand. 1992; 71:191-196.
69. Herabutya Y, Prasertsawat PO. Second trimester abortion using intravaginal misoprostol. Int J Gynecol Obstet. 1998;60:161-165.
70. 1 methyl ester) vaginal pessaries in the early second trimester. Prostaglandins. 1987;34:111-117.
71. Nuutila M, Toivonen J, Ylikorkala O, Halmesmaki E. A comparison between two doses of intravaginal misoprostol and gemeprost for induction of second-trimester abortion. Obstet Gynecol. 1997;90:896-900.
72. Wong KS, Ngai CSW, Wbng AYK, Ho PC. Vaginal misoprostol compared with vaginal gemeprost in termination of second trimester pregnancy. Contraception. 1998;58:207-210.
73. Jain JK, Mishell DR. A comparison of misoprostol with and without laminaria tents for induction of second-trimester abortion. Am J Obstet Gynecol. 1996;175:173-177.
74. UK Multicenter Study. Oral mifepristone 600 mg and vaginal gemeprost for mid-trimester induction of abortion: An open multicenter study. Contraception. 1997;56: 361-366.
75. Ho PC, Chan YF, Lau W. Misoprostol is as effective as gemeprost in termination of second trimester pregnancy when combined with mifepristone: A randomized comparative trial. Contraception. 1996;53: 281-283.
76. 2 versus concentrated oxytocin. Am J Obstet Gynecol. 1992;167:1112-1116.
77. 2 vaginal suppositories for second-trimester pregnancy termination. Obstet Gynecol. 1996;88:110-113.
78. 2 for second trimester pregnancy termination. J Matern Fetal Med. 1999;8:48-50.
79. Ramin KD, Ogbum PL Jr, Danilenko-Dixon D, Ramsey PS. High-dose misoprostol for midgestation pregnancy interruption. Am J Obstet Gynecol 2000;182:S137.
80. Lauersen NH, Birnbaum S. Water intoxication associated with oxytocin administration during saline-induced abortion. Am J Obstet Gynecol. 1975;121:2-6.
81. Schneider D, Bukovsky I, Caspi E. Safety of midtrimester pregnancy termination by laminaria and evacuation in patients with previous cesarean section. Am J Obstet Gynecol. 1994;171:554-557.
82. 2α in patients with previous cesarean section: Clinical course and potential for uterine rupture. Am J Obstet Gynecol. 1980;138:55-59.
83. Chapman SJ, Crispens M, Owen J, Savage K. Complications of midtrimester pregnancy termination: The effect of prior cesarean delivery. Am J Obstet Gynecol. 1996;175:889-892.
84. 1-methyl ester (gemeprost) for fetuses with a neural tube defect or hydrocephalus. Aust NZ J Obstet Gynaecol. 1996;36:300-302.
85. Goepfert AR, Owen J, Hauth JC. Prediction of failed midtrimester medical termination of pregnancy. Am J Obstet Gynecol. 1998; 174:341.
86. Lurie S, Appelman Z, Katz, Z. Curettage after midtrimester termination of pregnancy: Is it necessary? J Reprod Med. 1991; 36:786-788.
87. Stroh G, Hinman AR. Reported live births following induced abortion: Two and one-half years' experience in upstate New York. Am J Obstet Gynecol. 1976;126:83-90.